Search Results - Anna Vassall

Refine Results
  1. 1

    A comprehensive framework for considering additional unintended consequences in economic evaluation by Liv Nymark, Anna Vassall

    Published in Cost Effectiveness and Resource Allocation (2020-08-01)
    Get full text
    Article


  2. 2

    Impact of COVID-19 restrictive measures on income and health service utilization of tuberculosis patients in India by Susmita Chatterjee, Palash Das, Anna Vassall

    Published in BMC Infectious Diseases (2022-08-01)
    Get full text
    Article


  3. 3

    The cost-effectiveness of using performance-based financing to deliver the basic package of health services in Afghanistan by Josephine Borghi, Karl Blanchet, Ahmad S Salehi, Anna Vassall

    Published in BMJ Global Health (2020-09-01)
    Get full text
    Article


  4. 4

    Modelling approaches for tuberculosis: are they realistic? – Authors' reply by Nicolas A Menzies, Gabriella B Gomez, Anna Vassall

    Published in The Lancet Global Health (2017-03-01)
    Get full text
    Article


  5. 5

    Factors influencing institutionalization of health technology assessment in Kenya by Rahab Mbau, Anna Vassall, Lucy Gilson, Edwine Barasa

    Published in BMC Health Services Research (2023-06-01)
    Get full text
    Article


  6. 6

    Factors Influencing the Institutionalization of Health Technology Assessment: A Scoping Literature Review by Rahab Mbau, Anna Vassall, Lucy Gilson, Edwine Barasa

    Published in Health Systems & Reform (2023-12-01)
    Get full text
    Article


  7. 7

    Political economy analysis of the performance‐based financing programme in Afghanistan by Ahmad Shah Salehi, Karl Blanchet, Anna Vassall, Josephine Borghi

    Published in Global Health Research and Policy (2021-03-01)
    Get full text
    Article


  8. 8

    Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment by Susmita Chatterjee, Palash Das, Aaron Shikhule, Radha Munje, Anna Vassall

    Published in PLOS Global Public Health (2023-02-01)
    Get full text
    Article


  9. 9

    Journey of the tuberculosis patients in India from onset of symptom till one-year post-treatment. by Susmita Chatterjee, Palash Das, Aaron Shikhule, Radha Munje, Anna Vassall

    Published in PLOS Global Public Health (2023-02-01)
    Get full text
    Article


  10. 10

    Catastrophic costs for tuberculosis patients in India: Impact of methodological choices. by Susmita Chatterjee, Palash Das, Guy Stallworthy, Gayatri Bhambure, Radha Munje, Anna Vassall

    Published in PLOS Global Public Health (2024-01-01)
    Get full text
    Article


  11. 11

    Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users. by Natasha K Martin, Ashley B Pitcher, Peter Vickerman, Anna Vassall, Matthew Hickman

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  12. 12

    “Going into the black box”: a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations by Heather Ingold, Heather Ingold, Gabriela B. Gomez, David Stuckler, Anna Vassall, Mitzy Gafos

    Published in Frontiers in Public Health (2024-03-01)
    Get full text
    Article


  13. 13

    Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully integrated modelling study. by Marcus R Keogh-Brown, Tom Sumner, Sedona Sweeney, Anna Vassall, Henning Tarp Jensen

    Published in PLoS Medicine (2024-12-01)
    Get full text
    Article


  14. 14

    The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. by Gabriela B Gomez, Annick Borquez, Kelsey K Case, Ana Wheelock, Anna Vassall, Catherine Hankins

    Published in PLoS Medicine (2013-01-01)
    Get full text
    Article


  15. 15

    Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries by Mariana Siapka, Michelle Remme, Carol Dayo Obure, Claudia B Maier, Karl L Dehne, Anna Vassall

    Published in Bulletin of the World Health Organization (2014-07-01)
    Get full text
    Article


  16. 16

    What are the priority-setting approaches for HIV/AIDS, TB and malaria programmes in Ghana? A qualitative perspective from key informants by Justice Nonvignon, Genevieve Cecilia Aryeetey, Richmond Owusu, Francis Ruiz, Anna Vassall, Augustina Koduah, Adjeiwa Akosua Affram

    Published in BMJ Public Health (2024-12-01)
    Get full text
    Article


  17. 17

    The cost and cost‐effectiveness of gender‐responsive interventions for HIV: a systematic review by Michelle Remme, Mariana Siapka, Anna Vassall, Lori Heise, Jantine Jacobi, Claudia Ahumada, Jill Gay, Charlotte Watts

    Published in Journal of the International AIDS Society (2014-01-01)
    Get full text
    Article


  18. 18

    Future support on evidence-informed priority setting and situational analysis of the potential role of Health Technology Assessment in Africa to support future pandemic preparednes... by Benjamin S. C. Uzochukwu, Chinyere Okeke, Francis Ruiz, Sergio Torres-Rueda, Joseph Kazibwe, Adaora Uzochukwu, Anna Vassall

    Published in Systematic Reviews (2024-07-01)
    Get full text
    Article


  19. 19

    Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations. by Alice Zwerling, Richard G White, Anna Vassall, Ted Cohen, David W Dowdy, Rein M G J Houben

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  20. 20

    What are economic costs and when should they be used in health economic studies? by Hugo C. Turner, Frank G. Sandmann, Laura E. Downey, Stacey Orangi, Yot Teerawattananon, Anna Vassall, Mark Jit

    Published in Cost Effectiveness and Resource Allocation (2023-05-01)
    Get full text
    Article


Search Tools: